registrieren | anmelden | FAQ      [?] 

Veterinary and Comparative Oncology

Articles from the last few issues of Veterinary and Comparative Oncology © Blackwell Publishing
  • Retrospective systematic study and quantitative analysis of cellular proliferation and apoptosis in normal, hyperplastic and neoplastic perianal glands in dogs
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 71-79.
  • Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 80-89.
  • Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 90-101.
    by Marconato, , Lorenzo, , Abramo, , Ratto, , Zini,
  • Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (19962004)
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 102-110.
    by Krick, , Little, , Patel, , Shofer, , Sorenmo, , Clifford, , Baez,
  • Dose-escalating vinblastine for the treatment of canine mast cell tumour
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 111-119.
    by Vickery, , Wilson, , Vail, , Thamm,
  • Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 120-125.
  • Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 126-132.
    by Thamm, , Obrien, , Vail,
  • Glucose transporter 1 expression in canine osteosarcoma
    Veterinary and Comparative Oncology, Vol. 6, No. 2. (June 2008), pp. 133-140.
    by Petty, , Lana, , Thamm, , Charles, , Bachand, , Bush, , Ehrhart,
  • Canine acute radiation dermatitis, a survey of current management practices in North America
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 197-207.
    by Flynn, , Lurie,
  • Expression of vascular endothelial growth factor in canine oral malignant melanoma
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 208-218.
  • Human granulocytemacrophage colony-stimulating factor DNA cationic-lipid complexed autologous tumour cell vaccination in the treatment of canine B-cell multicentric lymphoma
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 219-231.
  • Expression of E-cadherin in canine anal sac gland carcinoma and its association with survival
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 232-238.
    by Polton, , Brearley, , Green, , Scase,
  • Postsurgical intra-incisional 5-fluorouracil in dogs with incompletely resected, extremity malignant spindle cell tumours: a pilot study
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 239-249.
  • Evaluation of the gene for inducible nitric oxide synthase as a radiosensitizer under hypoxic and oxic conditions
    Veterinary and Comparative Oncology, Vol. 5, No. 4. (December 2007), pp. 250-255.
    by Turek, , Padilla, , Argyle,
  • Veterinary cancer registries in companion animal cancer: a review
    Veterinary and Comparative Oncology, Vol. 5, No. 3. (September 2007), pp. 133-144.
  • Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia
    Veterinary and Comparative Oncology, Vol. 5, No. 3. (September 2007), pp. 145-155.
  • Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (19972004)
    Veterinary and Comparative Oncology, Vol. 5, No. 3. (September 2007), pp. 156-167.
  • Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours
    Veterinary and Comparative Oncology, Vol. 5, No. 3. (September 2007), pp. 168-176.
    by Hayes, , Adams, , Smith, , Maglennon, , Murphy,
  • A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma
    Veterinary and Comparative Oncology, Vol. 5, No. 3. (September 2007), pp. 177-196.
  • Chemotherapy during pregnancy: a review of the literature
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 61-75.
  • Is cancer a stem cell disease? Theory, evidence and implications
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 76-89.
  • Characterization of the biological behaviour of appendicular osteosarcoma in Rottweilers and a comparison with other breeds: a review of 258 dogs
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 90-98.
    by Mcneill, , Overley, , Shofer, , Kent, , Clifford, , Samluk, , Haney, , Van Winkle, , Sorenmo,
  • Inhibition of telomerase in canine cancer cells following telomestatin treatment
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 99-107.
    by Long, , Argyle, , Gault, , Nasir,
  • Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 108-118.
    by Zacchetti, , Van Garderen, , Rutteman,
  • Protein expression profiling of normal and neoplastic canine prostate and bladder tissue
    Veterinary and Comparative Oncology, Vol. 5, No. 2. (June 2007), pp. 119-130.
  • Cancer, cyclo-oxygenase and nonsteroidal anti-inflammatory drugs can we combine all three?
    Veterinary and Comparative Oncology, Vol. 5, No. 1. (March 2007), pp. 1-13.
    by Hayes,
  • Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model
    Veterinary and Comparative Oncology, Vol. 5, No. 1. (March 2007), pp. 14-30.
    by Lupu, , Storb,
  • Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (19992002)
    Veterinary and Comparative Oncology, Vol. 5, No. 1. (March 2007), pp. 31-37.
  • Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients
    Veterinary and Comparative Oncology, Vol. 5, No. 1. (March 2007), pp. 38-46.
  • 3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell line
    Veterinary and Comparative Oncology, Vol. 5, No. 1. (March 2007), pp. 47-58.
    by Alvarez, , Murahari, , Couto, , Rosol, , Kulp, , Chen, , Kisseberth,
  • Interactions between radiation therapy and immunotherapy: the best of two worlds?
    Veterinary and Comparative Oncology, Vol. 4, No. 4. (December 2006), pp. 189-197.
    by Thamm,
  • Microvascular growth of 7,12-dimethylbenz()anthracene-induced adenocarcinomas in rats: histology and scanning electron microscopy of resin casts
    Veterinary and Comparative Oncology, Vol. 4, No. 4. (December 2006), pp. 198-208.
  • Coarse fractionated radiation therapy for pituitary tumours in cats: a retrospective study of 12 cases
    Veterinary and Comparative Oncology, Vol. 4, No. 4. (December 2006), pp. 209-217.
  • High-dose-rate brachytherapy for intranasal tumours in dogs: results of a pilot study
    Veterinary and Comparative Oncology, Vol. 4, No. 4. (December 2006), pp. 218-231.
  • Development of a new canine osteosarcoma cell line
    Veterinary and Comparative Oncology, Vol. 4, No. 4. (December 2006), pp. 232-240.
  • Breed, gender and neutering status of British dogs with anal sac gland carcinoma
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 125-131.
    by Polton, , Mowat, , Lee, , Mckee, , Scase,
  • Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRa and c-Met in canine primary brain tumours
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 132-140.
  • Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: correlation with Ki67 immunoreactivity
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 141-150.
    by Renwick, , Argyle, , Long, , Nixon, , Gault, , Nasir,
  • Mohs micrographic surgery: a technique for total margin assessment in veterinary cutaneous oncologic surgery
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 151-160.
  • Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells effects on downstream targets Wip1 and p21/Cip1
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 161-177.
    by Deinnocentes, , Li, , Sanchez, , Bird,
  • Cytological comparison of fine-needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumours and an ultrasonographically normal appearing liver and spleen
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 178-183.
  • Telomerase activity in canine osteosarcoma
    Veterinary and Comparative Oncology, Vol. 4, No. 3. (September 2006), pp. 184-187.
    by Kow, , Bailey, , Williams, , Withrow, , Lana,
  • Histiocytic sarcomas in flat-coated retrievers: a summary of 37 cases (November 1998March 2005)
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 63-74.
  • A feasibility study of low-dose total body irradiation for relapsed canine lymphoma
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 75-83.
  • Feline head and neck squamous cell carcinoma: a natural model for the human disease and development of a mouse model
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 84-97.
  • Palliative radiotherapy as treatment for non-resectable soft tissue sarcomas in the dog a report of 15 cases
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 98-103.
  • Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 104-113.
  • Clinical usefulness of intradermal fluorescein and patent blue violet dyes for sentinel lymph node identification in dogs
    Veterinary and Comparative Oncology, Vol. 4, No. 2. (June 2006), pp. 114-122.
    by Wells, , Bennett, , Walsh, , Owens, , Peauroi,
  • Evaluation of risk and clinical outcome of mast cell tumours in pug dogs
    Veterinary and Comparative Oncology, Vol. 4, No. 1. (March 2006), pp. 2-8.
    by Mcniel, , Prink, , O'Brien,
  • Toxicity and biodistribution of an iodine-131-radiolabelled tumour necrosis-targeting antibody in non-tumour-bearing domestic felines
    Veterinary and Comparative Oncology, Vol. 4, No. 1. (March 2006), pp. 9-20.
    by Van Walleghen, , Parseghian,
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/journal/bsc-vco

    Result page: 1 2 3 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.